WilliamPolar/POLAR-trial-genomic-analysis: POLAR Nature Medicine – Initial Code Release

20260 citationsOthergreen Open Access

Authors

sPARK Lab @MSK · Motlow State Community College

Abstract

Initial public release of code and processed datasets supporting: Park et al. Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: phase 2 POLAR trial. Nature Medicine (2026). This release corresponds to the accepted manuscript version.

Topics & Keywords

Publication Details

Published in: Zenodo (CERN European Organization for Nuclear Research)

DOI: 10.5281/zenodo.18643675

Command Palette

WilliamPolar/POLAR-trial-genomic-analysis: POLAR Nature Medicine – Initial Code Release

Authors

Abstract

Topics & Keywords

Publication Details